Among Fosamax lawyers, all eyes are on the federal court in Manhattan, where the first jaw necrosis trial is underway. The case is the first of three cases scheduled for trial out of about 900 Fosamax lawsuits that are pending throughout the United States. While the… Read More
Although Merck & Co. has suggested that Fosamax side effects do not increase the risk of osteonecrosis of the jaw (ONJ), or only present a negligible risk, recent research has found that about 4% of users developed Fosamax ONJ problems, and the risk was seen even… Read More
Last week we wrote about a study published in the current issue of the Journal of the American Dental Association which confirms the link between Fosamax and jaw necrosis. Now an FDA official from the agency's division of drug risk assessment indicates that Fosamax side effects… Read More
The Fosamax lawyers at Saiontz & Kirk, P.A. have been representing clients since 2006 who developed osteonecrosis of the jaw after taking the oral osteoporosis drug. Although Merck has denied that their drug causes osteonecrosis of the jaw (ONJ), new research confirms that Fosamax jaw side… Read More
The first Fosamax jaw damage lawsuit is scheduled for trial in the federal MDL in August 2009, and it will be followed by additional trials in October 2009 and January 2010. The Fosamax lawyers at Saiontz & Kirk, P.A. are continuing to review potential cases for… Read More
The osteoporosis drug Fosamax has been associated with the development of a serious and disfiguring jawbone condition known as osteonecrosis of the jaw. Although Merck has been aware of the painful and life-changing side effect for some time, they continue to provide inadequate Fosamax warnings to… Read More
According to a report published last week by Lloyds Corporate Litigation Reporter, Merck & Co., Inc. faced approximately 655 Fosamax lawsuits involving over 1,000 plaintiff groups as of June 30, 2008. The lawsuits were filed on behalf of users who have suffered a disfiguring jaw condition,… Read More
New research suggests that use of Fosamax may increase the risk of a rare type of low-energy femur fracture. Prolonged use of the osteoporosis drug may overly suppress bone metabolism, impacting the ability of the bone to repair microdamage to the femur. >>INFORMATION: Lawsuits over a… Read More
Two new studies in the Archives of Internal Medicine provide new evidence about side effects of Avandia, Actos and Fosamax. One study established a heightened risk of bone fractures among Avandia and Actos users. The other study found a connection between women who used the osteoporosis… Read More
The lawyers at Saiontz & Kirk, P.A. currently represent individuals who are pursuing lawsuits after developing osteonecrosis of the jaw as a side effect of Fosamax. A new study indicates that the popular osteoporosis drug could also increase the risk of developing osteonecrosis of the knee,… Read More
